Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic liver disease in children and adolescents worldwide. Simultaneously to the epidemic spreading of childhood obesity, the rate of affected young has dramatically increased in the last decades with an estimated p...

Full description

Bibliographic Details
Main Authors:	Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, Francesco Chiarelli, Cosimo Giannini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Endocrinology
Subjects:	non-alcoholic fatty liver disease liver steatosis steatohepatitis obesity in children metabolic syndrome insulin resistance
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.639548/full

Similar Items

Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis
by: Carine L. Panke, et al.
Published: (2020-01-01)

Insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
by: Esther Ubiña-Aznar, et al.

Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.
by: Vishal eGhevariya, et al.
Published: (2014-03-01)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
by: Yiyoung Kwon, et al.
Published: (2022-04-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
by: D Shyangdan, et al.
Published: (2011-11-01)

THE COURSE OF CHRONIC KIDNEY DISEASE (CHRONIC PYELONEPHRITIS) IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND OBESITY
by: Aliona A. Antoniv, et al.
Published: (2021-09-01)

New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
by: Antônio R. Andrade, et al.
Published: (2017-11-01)

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01)

Ultrasound steatometry in patients with non-alcoholic fatty liver disease: pilot results
by: Darya Yu. Venidiktova, et al.
Published: (2019-04-01)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
by: Teresa Auguet, et al.
Published: (2014-12-01)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG OBESE PREGNANT WOMEN
by: I. O. Makarov, et al.
Published: (2016-09-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)

Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study
by: Anne Thushara Matthias, et al.
Published: (2018-08-01)

USING NON-INVASIVE BIOMARKERS AND PLACE OF CYTOKERATIN 18 IN DIAGNOSIS PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: N. V. Dynnyk
Published: (2016-04-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
by: Maria Corina Plaz Torres, et al.
Published: (2020-05-01)

The diagnostic conundrum in non-alcoholic fatty liver disease
by: Valerio Rosato, et al.
Published: (2020-10-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

Insulin-like Growth Factor Binding Proteins and Cellular Senescence Are Involved in the Progression of Non-Alcoholic Fatty Liver Disease and Fibrosis in a Mouse Model
by: Carolina Guzmán, et al.
Published: (2024-03-01)

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients
by: Rubén Díez-Rodríguez, et al.
Published: (2014-12-01)

Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2021-02-01)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
by: Clarissa Berardo, et al.
Published: (2020-12-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-03-01)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
by: Nancy Magee, et al.
Published: (2022-12-01)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Published: (2013-12-01)

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action
by: Vanessa D. de Mello, et al.
Published: (2017-04-01)

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
by: V. T. Ivashkin, et al.
Published: (2022-12-01)

The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease
by: A A Shipovskaya, et al.
Published: (2018-08-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids
by: Grayson W. Way, et al.
Published: (2022-04-01)

Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)

Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan
by: Hisanaga Yasuhiro, et al.
Published: (2011-09-01)

A CLINICAL CASE OF DRUG HEPATITIS A WOMAN WHO IS PREGNANT WITH OBESITY
by: I. O. Makarov, et al.
Published: (2016-05-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison
by: Fábio Henrique Ribeiro Maldonado, et al.
Published: (2023-06-01)